eli lilly retatrutide clinical trials Lilly's triple agonist achieves 16.8% weight loss in phase 3 trial New GLP-1 obesity drug, retatrutide,

Balagtas, J., Bryant, E., and Hubbell, C

We think a lot about how to change the game, Hern said, noting that individuals with a BMI of 40 or higher have a life expectancy that is 10 to 15 years shorter than those without obesity

These foods are rich in fiber, vitamins, minerals and phytonutrients with antioxidant properties

Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models

While prescription weight loss medications have been on the market for decades, such as phentermine, the newer GLP-1s, including Ozempic (used off-label for weight loss) and Wegovy, have been generally shown to be more effective than previous treatments

Your doctor can help determine that and advise accordingly